Skip to main content
SpringerLink
Log in
Book cover

Neuro-Psychopharmaka Ein Therapie-Handbuch pp 1–102Cite as

Pharmakotherapie neuropsychiatrischer Notfall- und Akutsituationen

  • Chapter

  • 1662 Accesses

Auszug

Im alltäglichen Sprachgebrauch verwendet man den Begriff „seelische Krise“ oft als Synonym für „psychiatrischen Notfall“. Jedoch führt eine seelische Krise keineswegs zwangsläufig zu einer psychiatrischen Notfallsituation. Als Differenzierungsmerkmal dient der Schweregrad einer Krise, der über die Dringlichkeit der Einleitung einer Behandlung entscheidet.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ananth J, Prameswaran S, Gunatilake S et al. (2004) Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry 65: 464–470

    PubMed  CAS  Google Scholar 

  • Bhanushali M, Tuite PJ (2004) The evaluation and management of patients with neuroleptic malignant syndrome. Neurol Clin 22(2): 389–411

    PubMed  Google Scholar 

  • Benkert O, Hippius H (2003) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Damsa C, Bumb A, Bianchi-Demicheli F et al. (2004) Dopamine-dependent side effects of selective serotonine reuptake inhibitors: a clinical review. J Clin Psychiatry 65: 1064–1068

    PubMed  CAS  Google Scholar 

  • Dittmann V, Ermer A (2002) Rechtliche Grundlagen psychiatrischer Diagnostik und Therapie. In: Gaebel W, Müller-Spahn F (Hrsg) Diagnostik und Therapie psychischer Störungen. Kohlhammer, Stuttgart Berlin Köln, S 1047–1077

    Google Scholar 

  • Grohmann R, Rüther E, Schmidt LG (Hrsg) (1994) Unerwünschte Wirkungen von Psychopharmaka. Ergebnisse der AMÜP-Studie. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Grohmann R, Müller-Oerlinghausen B, RÜTHER E (2004) 25 Years of drug surveillance in psychiatry. Pharmacopsychiatry 37: 1–88

    Google Scholar 

  • Hall RCW, Popkin MU, Devaul RA et al. (1978) Physical illness presenting as psychiatric disease. Arch Gen Psychiatry 35: 1315–1320

    PubMed  CAS  Google Scholar 

  • Heinemann F, Assion H, Hermes G et al. (1997) Paroxetin-induziertes malignes neuroleptisches Syndrom. Nervenarzt 68: 664–666

    PubMed  CAS  Google Scholar 

  • Hewer W, Lederbogen F (Hrsg) (1998) Internistische Probleme bei psychiatrischen Erkrankungen. Enke, Stuttgart

    Google Scholar 

  • Hillard J (1990) Manual of clinical emergency psychiatry. American Psychiatric Press, Washington

    Google Scholar 

  • Hyman S, Tesar G (1994) Manual of psychiatric emergencies. Little Brown and Co, Boston

    Google Scholar 

  • Kindt H (1998) Forensische Fragen bei Notfallentscheidungen. In: Hewer W, Rössler W (Hrsg) Das Notfallpsychiatriebuch. Urban und Schwarzenberg, München Wien, S 74–88

    Google Scholar 

  • LaBruzza AL (1987) Physical illness presenting a psychiatric disorder: guidelines for differential diagnosis. J Operat Psychiatry 12: 24–31

    Google Scholar 

  • Müller-Spahn F, Bondy B (1985) Psychopharmaka und Verkehrssicherheit. Diagnostik 18: 11–17

    Google Scholar 

  • Müller-Spahn F, Buchheim P (1992) Diagnose, Differenzialdiagnose und Therapie des Alkoholentzugssyndroms mit Delir. Intensivmed [Suppl 1]: 61–66

    Google Scholar 

  • Müller-Spahn F, Hippius H, Schmauss M (1988) Der psychiatrische Notfall. medwelt 39: 1177–81

    Google Scholar 

  • Müller-Spahn F, Hoffmann-Richter U (2000) Psychiatrische Notfälle. Kohlhammer, Stuttgart Berlin Köln

    Google Scholar 

  • Müller-Spahn F, Hoffmann-Richter U (2002) In: Gaebel W, Müller-Spahn F (Hrsg) Diagnostik und Therapie psychischer Störungen. Kohlhammer, Stuttgart Berlin Köln, S 1114–1142

    Google Scholar 

  • Powell G, Caan W, Crowe M (1994) What events precede violent incidents in psychiatric hospitals? Br J Psychiatry 165: 107–112

    PubMed  CAS  Google Scholar 

  • Rupp M (1996) Notfall Seele. Methodik und Praxis der ambulanten psychiatrisch-psychotherapeutischen Notfall-und Krisenintervention. Thieme, Stuttgart

    Google Scholar 

  • Schnyder U (1993) Ambulante Krisenintervention. In: SCHNYDER U, SAUVANT J (Hrsg) Krisenintervention in der Psychiatrie. Hans Huber, Bern Göttingen Toronto, S 55–84

    Google Scholar 

Literatur

  • Ahrens B (1997) Suizidalität. Psychopharmakotherapie 4[Suppl 5]: 28–29

    Google Scholar 

  • Althaus D, Hegerl U (2001) Evaluation suizidpräventiver Maßnahmen. Nervenarzt 72: 672–684

    Google Scholar 

  • Arora RC, Meltzer HY (1989) Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry 146: 730–736

    PubMed  CAS  Google Scholar 

  • Asberg M, Nordström P (1988) Biological correlates of suicidal behavior. In: Möller HJ et al. (eds) Current issues of suicidology. Springer, Berlin Heidelberg New York, pp 223–241

    Google Scholar 

  • Asberg M, Transman L, Thoren P (1976) 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor? Arch Gen Psychiatry 33:1193–1197

    PubMed  CAS  Google Scholar 

  • Avery D, Winokur G (1978) Suicide, attempted suicide, and relapse rates in depression. Arch Gen Psychiatry 35: 749–753

    PubMed  CAS  Google Scholar 

  • Baldessarini R, Tondo L, Hennen J (1999) Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. J Clin Psychiatry 60[Suppl 2]: 77–84

    PubMed  CAS  Google Scholar 

  • Breier A, Astrachan BM (1984) Characterization of schizophrenic patients who commit suicide. Am J Psychiatry 141: 206–209

    PubMed  CAS  Google Scholar 

  • Bronisch T, Felber W, Wolfersdorf M (Hrsg) (2001) Neurobiologie suizidalen Verhaltens. Roderer, Regensburg

    Google Scholar 

  • Brunner J, Bronisch T (2002) Genetik und Neurobiologie suizidalen Verhaltens — Implikationen für Psychopharmakotherapie und Psychotherapie. Psychotherapie 7: 260–272

    Google Scholar 

  • Buckley N, Mcmanus P (1998) Fatal toxicity of drugs used in the treatment of psychotic illnesses. Br J Psychiatry 172: 461–464

    PubMed  CAS  Google Scholar 

  • Bürk F, Kurz A, Möller HJ (1985) Suicide risk scales: do they help to predict suicidal behaviour? Eur Arch Psychiatr Neurol Sci 235: 153–157

    Google Scholar 

  • Demling J (1995) Neurobiochemie suizidalen Verhaltens. In: Wolfersdorf M, Kaschka W (Hrsg) Suizidalität. Die biologische Dimension. Springer, Berlin Heidelberg New York Tokyo, S 47–72

    Google Scholar 

  • Engström G, Alling C, Blennow K et al. (1999) Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Eur Neuropsychopharmacol 9: 399–405

    PubMed  Google Scholar 

  • Farmer RDT, Pinder RM (1989) Why do fatal overdose rates vary between antidepressants? Acta Psychiatr Scand 80[Suppl 354]: 25–35

    Google Scholar 

  • Franke C, Roider S, Wolfersdorf M et al. (2002) Zusammenhang zwischen Suizidalität und Psychopharmaka. Ergebnisse der AMÜP-Bayern 1991 bis 1999. Psychopharmakotherapie 9: 108–111

    Google Scholar 

  • Frey R, Schreinzer D, Stimpfl T et al. (2002) Letale Intoxikationen mit Antidepressiva und Neuroleptika. Nervenarzt 73: 629–636

    PubMed  CAS  Google Scholar 

  • Goodwin F (2003) Reduced suicidality in bipolars with lithium. JAMA 290: 1467–1473

    PubMed  CAS  Google Scholar 

  • Haenel T (1989) Suizidhandlungen. Neue Aspekte der Suizidologie. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Häfner H, Helmchen H (1978) Psychiatrischer Notfall und psychiatrische Krise — Konzeptuelle Fragen. Nervenarzt 49: 82–87

    PubMed  Google Scholar 

  • Hall RCW, Zisook S (1981) Paradoxical reactions to benzodiazepines. Br J Clin Pharmacol 11:S 99–104

    Google Scholar 

  • Hawton K, Townsend E, Arensmen F et al. (2001) Psychosocial and pharmacological treatments for deliberate self harm. In: The Cochrane Library, Issue 4. Update Software, Oxford

    Google Scholar 

  • Healy D (1994) The fluoxetine and suicide controversy. A review of the evidence. CNS Drugs 1: 223–231

    Google Scholar 

  • Henry J (1997) Epidemiology and relative toxicity of antidepressant drugs in overdose. Drug Saf 16: 374–390

    PubMed  CAS  Google Scholar 

  • Hyman SE (1988) Der suizidale Patient. In: Hyman SE (Hrsg) Psychiatrische Notfälle. Enke, Stuttgart, S 15–22

    Google Scholar 

  • Inman WHW (1988) Blood disorders and suicide in patients taking mianserin or amitriptyline. Lancet i: 90–92

    Google Scholar 

  • Inskip H, Harris E, Barraclough B (1998) Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br J Psychiatry 172:35–37

    PubMed  CAS  Google Scholar 

  • Isacsson G, U B, Rich Charles L (1996) Epidemiological data suggest antidepressants reduce suicide risk among depressives. J Affect Disord 41: 1–8

    PubMed  CAS  Google Scholar 

  • Laux G, König W, Baumann P (1997) Infusionstherapie bei Depressionen, 4. Aufl. Hippokrates, Stuttgart

    Google Scholar 

  • Leonard BE (1989) Suicide prevention and antidepressants. Acta Psychiatr Scand 80[Suppl 354]

    Google Scholar 

  • Lindner R, Fiedler G, Götze P (2003) Diagnostik der Suizidalität. Dtsch Ärztebl 100: A 1004–1007

    Google Scholar 

  • Lindström M, Ryding E, Bosson P et al. (2004) Impulsivity related to brain serotonin transporter binding capacity in suicide attempters. Eur Neuropsychopharmacol 14: 295–300

    PubMed  Google Scholar 

  • Linehan M (1997) Behavioral treatments of suicidal behaviors: definitional obfuscation and treatment outcome. Ann NY Acad Sci 836:302–328

    PubMed  CAS  Google Scholar 

  • Mann JJ, Arango V, Marzuk PM et al. (1989) Evidence for the 5-HT hypothesis of suicide. A review of post-mortem studies. Br J Psychiatry 155[Suppl 8]: 7–14

    Google Scholar 

  • Meltzer H, Alphs L, Al G et al. (2003) Clozapine treatment for suicidality in schizophrenia. Arch Gen Psychiatry 60: 82–91

    PubMed  CAS  Google Scholar 

  • Miles CP (1977) Conditions predisposing to suicide: a review. J Nerv Ment Dis 164: 231–246

    PubMed  CAS  Google Scholar 

  • Modestin J, Schwarzenbach F (1992) Effect of psychopharmacotherapy on suicide risk in discharged psychiatric inpatients. Acta Psychiatr Scand 85: 173–175

    PubMed  CAS  Google Scholar 

  • Möller HJ (1992) Antidepressants — do they decrease or increase suicidality? Pharmacopsychiatry 25: 249–253

    PubMed  Google Scholar 

  • Möller HJ (2004) SSRI zu Recht unter Anklage? Psychopharmakotherapie 11: 69–70

    Google Scholar 

  • Möller HJ, Lauter H (1985) Der psychiatrische Liaisondienst. Münch Med Wochenschr 127:842–845

    Google Scholar 

  • Möller HJ, Steinmeyer EM (1994) Are serotonergic reuptake inhibitors more potent in reducing suicidality? An empirical study on paroxetine. Eur Neuropsychopharmacol 4:55–59

    PubMed  Google Scholar 

  • Montgomery SA, Pinder RM (1987) Do some antidepressants promote suicide? Psychopharmacology 92: 265–266

    PubMed  CAS  Google Scholar 

  • Montgomery SA, Dunner D, Dunbar G (1995) Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur Neuropsychopharmacol 5: 5–13

    PubMed  CAS  Google Scholar 

  • Muijen M, Roy D, Silverstone T et al. (1988) A comparative clinical trial of fluoxetine, mianserin and placebo with depressed outpatients. Acta Psychiatr Scand 78: 384–390

    PubMed  CAS  Google Scholar 

  • Müller-Oerlinghausen B (2003) How should findings on antisuicidal effects of lithium be integrated into practical treatment decisions? Eur Arch Psychiatry Clin Neurosci 253: 126–131

    PubMed  Google Scholar 

  • Müller-Oerlinghausen B, Wolf T, Ahrens B et al. (1994) Mortality during initial and during later lithium treatment. A collaborative study by the International Group for the Study of Lithiumtreated patients. Acta Psychiatr Scand 90: 295–297

    PubMed  Google Scholar 

  • Ohberg A, Vuori E, Klaukka T et al. (1998) Antidepressants and suicide mortality. J Affect Disord 50: 225–233

    PubMed  CAS  Google Scholar 

  • Pajonk F, Bartels H, Biberthaler P et al. (2001) Der psychiatrische Notfall im Rettungsdienst. Nervenarzt 72: 685–692

    PubMed  CAS  Google Scholar 

  • Pokorny AD (1983) Prediction of suicide in psychiatric patients. Arch Gen Psychiatry 40: 249–257

    PubMed  CAS  Google Scholar 

  • Pöldinger W (1982) Erkennung und Beurteilung der Suizidalität. In: Reimer C (Hrsg) Suizid. Springer, Berlin Heidelberg New York, S 13–21

    Google Scholar 

  • Pöldinger W, Sonneck G (1980) Die Abschätzung der Suizidalität. Nervenarzt 51: 147–151

    PubMed  Google Scholar 

  • Reimer C (1982) (Hrsg) Suizid. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Roy A (1982a) Risk factors for suicide in psychiatric patients. Arch Gen Psychiatry 39: 1089–1095

    PubMed  CAS  Google Scholar 

  • Roy A (1982b) Suicide in chronic schizophrenia. Br J Psychiatry 141: 171–177

    PubMed  CAS  Google Scholar 

  • Rush AJ, Beck AT (1978) Cognitive therapy of depression and suicide. Am J Psychother 32:201–219

    PubMed  CAS  Google Scholar 

  • Rutz W, von Knorring L, Walinder J (1989) Frequency of suicide on Gotland after systematic postgraduate education on general practitioners. Acta Psychiatr Scand 80: 151–154

    PubMed  CAS  Google Scholar 

  • Rutz W, von Knorring, L, Walinder J (1992) Long-term effects of an educational program for general practitioners given by the Swedish Committee for the Prevention and Treatment of Depression. Acta Psychiatr Scand 85: 83–88

    PubMed  CAS  Google Scholar 

  • Schmidtke A, Schaller S (1981) Möglichkeiten und Grenzen testpsychologischer Diagnostik suizidalen Verhaltens. In: Welz R et al. (Hrsg) Selbstmordhandlungen. Beltz, Weinheim, S 222–295

    Google Scholar 

  • Schmidtke A, Weinacker B, Löhr C et al. (2002) Suicide and suicide attempt rates and trends in Europe 1989–1999. Results of the WHO/EURO multicentre study on suicidal behaviour. Hogrefe, Göttingen

    Google Scholar 

  • Schou M, Weeke A (1988) Did manic-depressive patients who committed suicide receive prophylactic or continuation treatment at the time? Br J Psychiatry 153: 324–327

    PubMed  CAS  Google Scholar 

  • Szanto K, Mulsant B, Houck P et al. (2003) Occurrence and course of suicidality during short-term treatment of late-life depression. Arch Gen Psychiatry 60: 610–617

    PubMed  Google Scholar 

  • Tandon R, Jibson MD (2003) Suicidal behavior in schizophrenia: diagnosis, neurobiology, and treatment implications. Curr Opin Psychiatry 16: 193–197

    Google Scholar 

  • Teicher M, Glod C, Cole JO (1990) Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 147: 207–210

    PubMed  CAS  Google Scholar 

  • Tondo L, Hennen J, Baldessarini R (2001) Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand 104: 163–172

    PubMed  CAS  Google Scholar 

  • Vitiello B, Swedo D (2004) Antidepressant medications in children. N Engl J Med 350:1489–1491

    PubMed  CAS  Google Scholar 

  • Wakelin JS (1988) The role of serotonin in depression and suicide: do serotonin reuptake inhibitors provide a key? Adv Biol Psychiatry 17:70–83

    Google Scholar 

  • Walker A, Lanza L, Arellano F et al. (1997) Mortality in current and former users of clozapine. Epidemiology 8: 671–677

    PubMed  CAS  Google Scholar 

  • Wilkinson G, Bacon NA (1984) A clinical and epidemiological survey of parasuicide and suicide in Edinburgh schizophrenics. Psychol Med 14: 899–912

    PubMed  CAS  Google Scholar 

  • Wolfersdorf M (2000) Der suizidale Patient in Klinik und Praxis. Wissenschaftliche Verlagsgesellschaft, Stuttgart

    Google Scholar 

Literatur

  • Beerman E, Edhag O (1978) Depressive effects of carbamazepine on idioventricular rhythm in man. BJM 2: 171–172

    Google Scholar 

  • Biggs JT, Spiker DG, Petit JM et al. (1977) Tricyclic antidepressant overdose: incidence of symptoms. JAMA 238: 135

    PubMed  CAS  Google Scholar 

  • Boehnert MT, Lovejoy FH (1985) Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med 323: 474

    Google Scholar 

  • Caravati EM, Bossart PJ (1991) Demographic and electrocardiographic factors associated with severe tricyclic antidepressant toxicity. Clin Toxicol 29: 31–43

    CAS  Google Scholar 

  • Cockhill LA, Remick RA (1987) Blood pressure effects of monoamine oxidase inhibitors — the highs and lows. Can J Psychiatry 32: 803–808

    PubMed  CAS  Google Scholar 

  • Dahl SG, Strandjord RE (1976) Pharmacokinetics of chlorpromazine after single and chronic dosage. Clin Pharmacol Ther 437–438

    Google Scholar 

  • DeVane CL (1994) Pharmacokinetics of the newer antidepressants: clinical relevance. Am J Med 97: 13S–23S

    PubMed  CAS  Google Scholar 

  • Durelli L, Massazza U, Cavallo R (1989) Carbamazepine toxicity and poisoning incidence: Clinical features and management. Med Toxicol/Adv Drug Exp 4: 95–101

    CAS  Google Scholar 

  • Dursun SM, Burke JG, Revelex MA (1995) Toxic serotonin syndrome or extrapyramidal side effects? [Letter to the editor] Br J Psychiatry 166: 401–402

    PubMed  CAS  Google Scholar 

  • Dyson EH, Simpson D, Prescott LF et al. (1987) Self-poisoning and therapeutic intoxication with lithium. Hum Toxicol 6: 325–329

    PubMed  CAS  Google Scholar 

  • Elkayam U, Frishman W (1980) Cardiovascular effects of phenothiazines. Am Heart J 100: 397–401

    PubMed  CAS  Google Scholar 

  • Ellison DW, Pentel PR (1989) Clinical features and consequences of seizures due to cyclic antidepressant overdose. Am J Emerg Med 7: 5

    PubMed  CAS  Google Scholar 

  • Erich JL, Shih RD, O’Connor RE (1995) “Pingpong” gaze in severe monoamine oxidase inhibitor toxicity. J Emerg Med 13: 653–655

    PubMed  CAS  Google Scholar 

  • Goldberg ND, Shindeman FE (1963) Species differences in the cardiac effects of monoamine oxidase inhibitor. J Pharmacol Exp Ther 136: 142–151

    Google Scholar 

  • Graudins A, Stearman A, Chan B (1998) Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med 16: 615–619

    PubMed  CAS  Google Scholar 

  • Guze BH, Baxter LR Jr (1986) The serotonin syndrome: case responsive to propranolol. J Clin Psychopharmacol 6: 119–120

    PubMed  CAS  Google Scholar 

  • Hegerl U, Althaus D, Niklewski G et al. (2003) Optimierte Versorgung depressiver Patienten und Suizidprävention. Dtsch Ärztebl 42: A 2732–2737

    Google Scholar 

  • Hojer J, Malmlund HO, Berg A (1993) Clinical features in 28 consecutive cases of laboratoryconfirmed massive poisoning with carbamazepine. Ann Pharmacother 27: 866–870

    Google Scholar 

  • Hulten BA, Heath A (1982) Clinical aspects of tricyclic antidepressant poisoning. Acta Med Scand 213: 275

    Google Scholar 

  • Jaeger A, Sauder P, Kopferschmitt J et al. (1993) When should dialysis be performed in lithium poisoning? A kinetic study in 14 cases of lithium poisoning. Clin Toxicol 31: 429–447

    CAS  Google Scholar 

  • Kemper A, Dunlop R, Pietro D (1983) Thioridazine-induced torsades de pointes: successful therapy with isoproterenol. JAMA 249: 2931–2936

    PubMed  CAS  Google Scholar 

  • Knudsen K, Abrahamsson J (1993) Effects of epinephrine and norepinephrine on hemodynamic parameters and arrhythmias during a continuous infusion of amitriptyline in rats. Clin Toxicol 31: 461–471

    CAS  Google Scholar 

  • Knudsen K, Abrahamsson J (1994) Effect of epinephrine, norepinephrine, magnesium sulfate and milrinone on survival and the occurence of arrhythmias in amitriptyline poisoning in the rat. Crit Care Med 22: 1851–1855

    PubMed  CAS  Google Scholar 

  • Kokan L, Dart RC (1996) Life threatening hypotension from venlafaxine overdose (abstract). J Toxicol Clin Toxicol 34: 559

    Google Scholar 

  • Langou RA, Van Dyke C, Tahan SR (1980) Cardiovascular manifestations of tricyclic antidepressant overdose. Am Heart J 100: 458–463

    PubMed  CAS  Google Scholar 

  • Leblanc M, Raymond M, Bonnardeaux A et al. (1996) Lithium poisoning treated by high-performance continuous arteriovenous and venovenous hemodiafiltration. Am J Kidney Dis 27: 365–372

    PubMed  CAS  Google Scholar 

  • Linden CH Rumack BH, Strehlke C (1984) Monoamine oxidase inhibitor overdose. Ann Emerg Med 13: 1137–1143

    PubMed  CAS  Google Scholar 

  • Litovitz TL, Felberg L, Soloway RA et al. (1998) 1997 Ann report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 16: 443–497

    PubMed  CAS  Google Scholar 

  • Litovitz TL, Troutman WH (1983) Amoxapine overdose-seizures and fatalities. JAMA 250: 1069

    PubMed  CAS  Google Scholar 

  • Mach von MA, Weilemann LS (2003) Aktuelle Therapie von Intoxikationen. Dtsch Med Wochenschr 128: 1779–1781

    Google Scholar 

  • Matell G, Thorstrand C (1967) A case of fatal nialamid poisoning. Acta Med Scand 181 (fasc 1): 79–82

    PubMed  CAS  Google Scholar 

  • Matley E, Wozniak KM (1984) Interactions of a non-selective monoamine oxidase inhibitor, tranylcypromine and nialamide, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake. J Psychiatr Res 18: 191–203

    Google Scholar 

  • Mills KC (1995) Serotonin syndrome. Am Fam Phys 52: 1475–1482

    CAS  Google Scholar 

  • Mills KC (1997) Serotonin syndrome: a clinical update. Med Toxicol 13: 763–783

    CAS  Google Scholar 

  • Mitchell AA, Lovejoy FH, Goldman P (1976) Drug ingestions associated with miosis in comatose children. J Pediatr 89: 303–305

    PubMed  CAS  Google Scholar 

  • Neuvonen PJ, Pohjola-Sintonen S, Tacke U et al. (1993) Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses. Lancet 342: 1410–1419

    Google Scholar 

  • Ostrom M (1996) Fatal overdose with citalopram. Lancet 348: 339

    PubMed  CAS  Google Scholar 

  • Pentel PR, Benowitz NL (1984) Efficacy and mechanism of action of sodium bicarbonate in the treatment of desipramine toxicity in rats. J Pharmacol Exp Ther 230: 12–19

    PubMed  CAS  Google Scholar 

  • Pentel PR, Benowitz NL (1986) Tricyclic antidepressant poisoning: management of arrhythmias. Med Toxicol 1: 101–121

    PubMed  CAS  Google Scholar 

  • Personne M, Sjoberg G, Persson H (1997) Citalopram overdose-review of cases treated in Svedish hospitals. Clin Toxicol 35: 237–240

    CAS  Google Scholar 

  • Peters RW, Buser GA, Kim HJ et al. (1992) Tricyclic overdose causing sustained monomorphic ventricular tachycardia. Am J Cardiol 70: 1226–1228

    PubMed  CAS  Google Scholar 

  • Preskorn SH (1997) Clinically relevant pharmacology of selective serotonin reuptake inhibitors: an overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Clin Pharmacokinet 32[Suppl]: 1–21

    PubMed  CAS  Google Scholar 

  • Ranger S, Sheldon R, Fermini B et al. (1993) Modulation of flecainide’s cardiac sodium channel blocking actions by extracellular sodium: a possible cellular mechanism for the action of sodium salts in flecainide cardiotoxicity. J Pharmacol Exp Ther 264: 1160–1167

    PubMed  CAS  Google Scholar 

  • Shannon M, Merola J, Lovejoy FH (1988) Hypotension in severe tricyclic antidepressant overdose. Am J Emerg Med 6: 439

    PubMed  CAS  Google Scholar 

  • Smith LM, Peroutka SJ (1986) Differential effects of 5-hydroxytryptamine 1A selective drugs on the 5-HAT behavioral syndrome. Pharmacol Biochem Behav 24: 1513–1519

    PubMed  CAS  Google Scholar 

  • Smith SW, Ling LL, Haistenson CE (1991) Whole-bowel irrigation as a treatment for acute lithium overdose. Ann Emerg Med 20: 536–539

    PubMed  CAS  Google Scholar 

  • Spiller HA, Krenzelok EP, Cookson E (1990) Carbamazepine overdose: a prospective study of serum levels and toxicity. Clin Toxicol 28: 445–458

    CAS  Google Scholar 

  • Tamargo J, Rodriguez S, Garcia de Jalon P (1979) Electophysiological effects of desipramine on guinea pig papillary muscles. Eur J Parmacol 55: 171

    CAS  Google Scholar 

  • Verrilli MR, Salanga VD, Kozachuk WE (1987) Phenelzine toxicity responsive to dantrolene. Neurology 37: 865–867

    PubMed  CAS  Google Scholar 

  • Watson WA, Cremer KF, Chapman JA (1986) Gastrointestinal obsruction associated with multiple-dose activated charcoal. J Emerg Med 4: 401–407

    PubMed  CAS  Google Scholar 

  • Wit AL, Cranefield PF, Hoffman BF (1972) Slow conduction and re-entry in the ventricular conducting system. Circ Res 30: 11

    PubMed  CAS  Google Scholar 

  • Zuber M, Elsasser S, Ritz R et al. (1988) Flumazenil (Anexate) in severe intoxication with carbamazepine (Tegretol). Eur Neurol 28: 161–163

    PubMed  CAS  Google Scholar 

Literatur

  • Al Samarrai S, Dunn J, Newmark T et al. (2003) Quetiapine for treatment resistant delirium. Psychosomatics 44: 350–351

    Google Scholar 

  • American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington DC

    Google Scholar 

  • American Psychiatric Association (1999) Practice guideline for the treatment of patients with delirium. Am J Pychiatry 156[Suppl]: 1–20

    Google Scholar 

  • American Psychiatric Association Task Force (1989) Treatment of psychiatric disorders. American Psychiatric Association, Washington DC, p 187

    Google Scholar 

  • Breitbart W, Marotta R, Platt MM et al. (1996) A double blind trial of haloperidol, chlorpromazine and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 153: 231–237

    PubMed  CAS  Google Scholar 

  • Breitbart W, Trembley A, Gibson C (2002) An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 43: 175–182

    PubMed  CAS  Google Scholar 

  • Carnes M, Howell T, Rosenberg M et al. (2003) Physicians vary in approaches to the clinical managemant of delirium. J Am Geriatr Soc 51: 234–239

    PubMed  Google Scholar 

  • Centorrino F, Albert MJ, Drago-Ferrante G (2003) Delirium during clozapine treatment: incidence and associated risk factors. Pharmacopsychiatry 36: 156–160

    PubMed  CAS  Google Scholar 

  • Cole M, Mccusker J, Dendukuri N et al. (2003) The prognostic significance of sybsyndromal delirium in elderly medical inpatients. J Am Geriatr Soc 51: 754–760

    PubMed  Google Scholar 

  • Daeppen JB, Gache P Landry U et al. (2002) Symptom triggert vs fixed-schedule doses of benzodiazepines for alcohol withdrawal: a randomized treatment trial. Arch Intern Med 162: 1117–1121

    PubMed  CAS  Google Scholar 

  • Davis MP, Dickerson ED (2001) Olanzapine: another psychotropic? Am J Hosp Palliat Care 18: 129–132

    PubMed  CAS  Google Scholar 

  • Eli EW, Gautam S, Margolin R et al. (2001) The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 27: 1892–1900

    Google Scholar 

  • Feuerlein W (1967) Klinisch-statistische Untersuchungen über die Entstehungsbedingungen und die Prognose des Alkoholdelirs. Nervenarzt 38: 492–500

    PubMed  CAS  Google Scholar 

  • Fick DM, Agostini JV, Inouye SK (2002) Delirium superimposed on dementia: a systematic review. J Am Geriatr Soc 50: 1723–1732

    PubMed  Google Scholar 

  • Franz M, Dlabal H, Kunz S et al. (2001) Treatment of alcohol withdrawal: tiapride and carbamazepine versus clomethiazole. A pilot study. Eur Arch Psychiatry Clin Neurosci 251: 185–192

    PubMed  CAS  Google Scholar 

  • Gallinat J, Möller H-J, Moser RL et al. (1999) Das postoperative Delir: Risikofaktoren, Prophylaxe und Therapie. Anaesthesist 48: 507–518

    PubMed  CAS  Google Scholar 

  • Gleason OC (2003) Donecepil for postoperative delirium. Psychosomatics 44: 437–438

    PubMed  Google Scholar 

  • Gustafson Y, Berggren D, Brannstrom B et al. (1988) Acute confusional states in elderly patients treated for femoral neck fracture. J Am Geriatr Soc 36: 525–530

    PubMed  CAS  Google Scholar 

  • Hassaballa HA, Balk RA (2003) Torsade de pointes associated with the administration of intravenous haloperidol: a review of the literature and practice guidelines for use. Expert Opin Drug Saf 2: 543–547

    PubMed  CAS  Google Scholar 

  • Hewer W, Förstl H (1994) Verwirrtheitszustände im höheren Lebensalter — eine aktuelle Literaturübersicht. Psychiat Prax 21: 131–138

    CAS  Google Scholar 

  • Horikawa N, Yamazyki T, Miyamoto K et al. (2003) Treatment for delirium with risperidone: results of a prospective open trial with 10 patients. Gen Hosp Psychiatry 25: 289–292

    PubMed  Google Scholar 

  • Inouye SK (1999) Predisposing and precipitating factors for delirium in hospitalized older patients. Dement Geriatr Cogn Disord 10: 393–400

    PubMed  CAS  Google Scholar 

  • Inouye SK, Bogardus ST, Carpentier PA Jr et al. (1999) A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340: 669–676

    PubMed  CAS  Google Scholar 

  • Inouye SK, Bogardus ST, Wlliams CS Jr (2003) The role of adherence on the effectiveness of nonpharmacologic interventions: evidence of the delirium prevention trial. Arch Intern Med 163: 958–964

    PubMed  Google Scholar 

  • Jeste DV, Caligiuri MP, Paulsen JS et al. (1995) Risk of tardive dyskinesia in older patients. Arch Gen Psychiatry 52: 756–765

    PubMed  CAS  Google Scholar 

  • Kim KY, Bader GM, Kotlyar V et al. (2003) Treatment of delirium in older adults with quetiapine. J Geriatr Psychiatry Neurol 16: 29–31

    PubMed  Google Scholar 

  • Lipowski ZJ (1990) Delirium — acute confusional states. Oxford University Press, Oxford

    Google Scholar 

  • Lucht M, Kühn KU, Arnbruster J et al. (2003) Alcohol withdrawal treatment in intoxicated vs non-intoxicated patients: a controlled open label study with tiapride/carbamezepin, clomethiazole and diazepam. Alcohol Alcoholism 38: 168–175

    CAS  Google Scholar 

  • Majumdar SK (1991) Chlormethiazole: current status in the treatment of the acute ethanol withdrawal syndrome. Drug Alcohol Depend 27: 201–207

    PubMed  CAS  Google Scholar 

  • Marcantonio E, Ta T, Duthie E et al. (2002) Delirium severity and psychomotor types: their relationship with outcomes after hip fracture repair. J Am Getriatr Soc 50: 850–857

    Google Scholar 

  • Massie MJ, Holland J, Glass E (1983) Delirium in terminally ill cancer patients. Am J Psychiatry 156[5 Suppl]: 1–20

    Google Scholar 

  • McCusker, Cole M, Dendukuri N (2001) Delirium in older medical inpatients and subsequent cognitive and functional status: a prospective study. JAMC 155: 575–583

    Google Scholar 

  • Mc Cusker J, Cole M, Abramowicz M et al. (2002) Delirium predicts 12-month mortality. Arch Intern Med 162: 457–463

    Google Scholar 

  • McNicoll L, Pisani MA, Zhang Y (2003) Delirium in the intensive care unit: occurrence and clinical course in the older patients. J Am Geriatr Soc 51: 591–598

    PubMed  Google Scholar 

  • Metzger E, Friedman R (1993) Prolongation of the corrected QT and torsade de pointes cardiac arrythmia associated with intravenous haloperidol in the medically ill. J Clin Psychopharmacol 13: 128–132

    PubMed  CAS  Google Scholar 

  • Moller JT, Jensen PF, Rasmussen LS et al. (1998) Long-term postoperative cognitive dysfunction in the elderly: ISPOCD 1 study. Lancet 351: 857–861

    PubMed  CAS  Google Scholar 

  • Peters DH, Faulds D (1994) Tiapride. A review of its pharmacology and therapeutic potential in the management of alcohol dependence syndrome. Drugs 47: 1010–1032

    PubMed  CAS  Google Scholar 

  • Rosenbaum M, McCarty T (2002) Alcohol prescription by surgeons in the prevention and treatment of delirium tremens: historic and current practice. Gen Hosp Psychiatry 24: 257–259

    PubMed  Google Scholar 

  • Ross CA, Peyser CE, Shapiro I et al. (1991) Delirium: phenomenologic and etiologic subtypes. Int Psychogeriatr 3: 135–147

    PubMed  CAS  Google Scholar 

  • Schuurmans MJ, Deschamps PI, Markham SW et al. (2003) The measurement of delirium: review of scales. Res Theory Nurs Pract 17: 207–224

    PubMed  Google Scholar 

  • Schwartz TL, Masand PS (2000) Treatment of delirium with quetiapine. Primary Care Companion J Clin Psychiatry 2: 10–12

    PubMed  Google Scholar 

  • Schwartz TL, Masand PS (2002) The role of atypical antipsychotics in the treatment of delirium. Psychosomatics 43: 228–233

    Google Scholar 

  • Sipahimalani A, Masand PS (1998) Olanzapine in the treatment of delirium. Psychosomatics 39: 422–430

    PubMed  CAS  Google Scholar 

  • Skrobik YK, Bergeron N, Dumont M et al. (2003) Olanzapine versus haloperidol: treating delirium in a critical care setting. Intensiv Care Med

    Google Scholar 

  • Targum SD (2001) Treating psychotic symptoms in elderly patients. Primary Care Companion J Clin Psychiatry 3: 156–163

    PubMed  Google Scholar 

  • Turker SB, Tavare CJ (2003) Delirium in children and adolescents. J Neuropsychiatry Clin Neurosci 15: 431–435

    Google Scholar 

  • Wengel SP, Roccaforte WH, Burke WJ (1998) Donezepil improves symptoms of delirium in dementia: implications for future research. J Geriatr Psychiatry Neurol 11: 159–161

    PubMed  CAS  Google Scholar 

  • WHO (1994) Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V — Forschungskriterien. Huber, Bern Göttingen Toronto Seattle

    Google Scholar 

  • Woodward M, Moran J, Elliot R et al. (2001) Delirium in the hospitalized elderly. Aust J Hosp Pharm 31: 35–40

    Google Scholar 

  • Zarate CA Jr, Balderassini RJ, Siegel AJ et al. (1997) Risperidone in the elderly: a pharmacoepidemiologic study. J Clin Psychiatry 58: 311–317

    PubMed  CAS  Google Scholar 

  • Zeleznik J (2001) Delirium: still searching for risk factors and effective preventive measures. J Am Geriatr Soc 49: 1729–1732

    Google Scholar 

Literatur

  • Allen MH, Currier GW (2004) Use of restraints and pharmacotherapy in academic emergency services. Gen Hosp Psychiatry 26: 42–49

    PubMed  Google Scholar 

  • Beauford JE, Mcniel DE, Binder RL (1997) Utility of the initial therapeutic alliance in evaluating psychiatric patients’ risk of violence. Am J Psychiatry 154: 1272–1276

    PubMed  CAS  Google Scholar 

  • Berzewski H (2002) Psychomotorische Erregungszustände. In: Berzewski H, Nickel B (Hrsg) Neurologische und psychiatrische Notfälle. Die Erstversorgung. Urban und Fischer, München Jena, pp 331–344

    Google Scholar 

  • Breier A, Meehan K, Birkett M et al. (2002) A double blind, placebo-controlled dose-response comparison of intramuscular olanzapin and haloperidol in the treatment of acute agitation in schizophrenia. Arch Gen Psychiatry 59: 441–448

    PubMed  CAS  Google Scholar 

  • Brieden T, Ujeyl M, Naber D (2002) Psychopharmacological treatment of aggression in schizophrenic patients. Pharmacopsychiatry 35:83–89

    PubMed  CAS  Google Scholar 

  • Briken P, Nika E, Krausz M et al. (2002) Atypische Neuroleptika in der Behandlung von Aggressivität und Feindseligkeit bei schizophrenen Patienten. Fortschr Neurol Psychiat 70: 139–144

    PubMed  CAS  Google Scholar 

  • Briken P, Nika E, Moritz S et al. (2002) Effect of zotepine, olanzapine and risperidone on hostility in schizophrenic patients. Schizophr Res 57: 311–313

    PubMed  Google Scholar 

  • Brook S (2003) Intramusclar ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia. J Clin Psychiatry 19[Suppl]: 13–18

    Google Scholar 

  • Chengappa KN, Vasile J, Levine J (2002) Clozapine: its impact on aggressive bevaviour among patients in a state psychiatric hospital. Schizophr Res 53: 1–6

    PubMed  CAS  Google Scholar 

  • Currier GW (2000) Atypical antipsychotic medications in the psychiatric emergency service. J Clin Psychiatry 61[Suppl]: 21–26

    PubMed  CAS  Google Scholar 

  • Daniel DG, Potkin SG, Reeves KR (2001) Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double blind, randomized trial. Psychopharmacology 155: 128–134

    PubMed  CAS  Google Scholar 

  • DeDeyn PP, Rabheru K, Rasmussen A et al. (1999) A randomized of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 53: 946–955

    CAS  Google Scholar 

  • Fontaine CS, Hynan LS, Koch K et al. (2003) A double blind comparison of olanzapine versus risperidone in the acute treatment of dementia-related behavioural disturbances in extended care facilities. J Clin Psychiatry 64:726–730

    PubMed  CAS  Google Scholar 

  • Geddes J, Freemantle N, Harrison P et al. (2000) Atypical antipsychotics in the treatment of schizophrenia: systematic overview and metaregression analysis. BMJ 321: 1371–1376

    PubMed  CAS  Google Scholar 

  • Katz IR, Jeste D, Mintzer J et al. (1999) Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized double-blind trial. J Clin Psychiatry 60: 107–115

    PubMed  CAS  Google Scholar 

  • Klotz SG, Preval H, Southard R (2003) Injectable Ziprasidone in the psychiatric emergency service. American Psychiatric Association (APA), 156th Meeting, San Francisco, pp 17–22 (Abstract)

    Google Scholar 

  • Leucht S, Pitschel-Walz G, Abraham D et al. (1999) Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: a meta-analysis of randomized controlled studies. Schizophr Res 35: 51–68

    PubMed  CAS  Google Scholar 

  • McKeith I, Del Ser T, Anand R et al. (2000) Rivastigmine provides symptomatic benefit in dementia with Lewy bodies: findigs from a placebo-controlled international multicenter study. Lancet 356: 2031–2036

    PubMed  CAS  Google Scholar 

  • McManus DQ, Arvanitis LA, Kowalcyk BB (1999) Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group. J Clin Psychiatry 60: 292–298

    PubMed  CAS  Google Scholar 

  • McNiel DE, Binder RE (1995) The relationship between acute psychiatric symptoms, diagnosis and short-term risk of violence. Hosp Commun Psychiatry 45: 133–137

    Google Scholar 

  • McNiel DE, Eisner JP, Binder RL (2000) The relationship between command hallucinations and violence. Pschiatr Serv 51: 1288–1292

    CAS  Google Scholar 

  • Meehan K, Zhang F, Davis S (2001) A double blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnose with bipolar mania. J Clin Psychopharmacol 21: 389–397

    PubMed  CAS  Google Scholar 

  • Meltzer HY (1999) The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21: 106–115

    Google Scholar 

  • Portainsson AP, Tariot PN, Erb R et al. (1997) An open trial of valproate for agitation in geriatric neuropsychiatric disorders. Am J Geriatr Psychiatry 5: 344–351

    Google Scholar 

  • Portainsson AP, Tariot PN, Erb R et al. (2001) Placebo-controlled study of divalproex sodium for agitation in dementia. Am J Geriatr Psychiatry 9: 58–66

    Google Scholar 

  • Street JS, Clark WS, Gannon KS et al. (2000) Olanzapine treatment of psychosis and behavioral disturbances in patients with Alzheimer’s disease in nursing care facilities. Arch Gen Psychiatry 57: 968–976

    PubMed  CAS  Google Scholar 

  • Targum SD, Abbott JL (2000) Efficacy of quetiapine in Parkinson’s patients with psychosis. J Clin Psychopharmacol 20: 54–60

    PubMed  CAS  Google Scholar 

  • Tariot PN, Jakimovich LJ, Erb R et al. (1999) Withdrawal from controlled carbamezepine therapy follewed by further carbamazepine treatment in patients with dementia. J Clin Psychiatry 60: 684–689

    PubMed  CAS  Google Scholar 

  • Tohen M, Jacobs TG, Grundy SL (2000) Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Arch Gen Psychiatry 57: 841–849

    PubMed  CAS  Google Scholar 

  • Zaudig M (2000) A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia. Drug Saf 23: 183–195

    PubMed  CAS  Google Scholar 

Literatur

  • Addonizio G, Susman VL, Roth SD (1986) Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. Am J Psychiatry 143:1587–1590

    PubMed  CAS  Google Scholar 

  • Assion HJ, Heinemann F, Laux G (1998) Neuroleptic malignant syndrome under treatment with antidepressants? A critical review. Eur Arch Psychiatry Clin Neurosci 248: 231–239

    PubMed  CAS  Google Scholar 

  • Assion HJ, Volz HP (2004) Malignes Neuroleptisches Syndrom. G Thieme, Stuttgart New York

    Google Scholar 

  • Benkert O, Hippius H (2003) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Boiteux J, Roubaud L, Gandelet N et al. (1997) Indications for electroconvulsive therapy. Encephale 23 Spec No 3: 21–26

    PubMed  Google Scholar 

  • Bräunig P, Krüger S, Shugar G (1999) Prevalence and clinical significance of catatonic symptoms in mania. Fortschr Neurol Psychiatr 67:306–317

    PubMed  Google Scholar 

  • Bush G, Fink M, Petrides G et al. (1996) Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 93: 137–143

    PubMed  CAS  Google Scholar 

  • Caroff SN, Mann SC, Campbell EC (2000) Atypical antipsychotics and neuroleptic malignant syndrome. Psychiatr Ann 30(5): 314–321

    Google Scholar 

  • Cassidy EM, O’Brien M, Osman MF et al. (2001) Lethal catatonia responding to high-dose olanzapine therapy. J Psychopharmacol 15: 302–304

    PubMed  CAS  Google Scholar 

  • Davis JM, Janicak PG, Sakkas P et al. (1991) Electroconvulsive therapy in the treatment of the neuroleptic malignant syndrome. Convuls Ther 7: 111–120

    PubMed  Google Scholar 

  • Fink M (1996) Neuroleptic malignant syndrome and catatonia: one entity or two? Biol Psychiatry 39: 1–4

    PubMed  CAS  Google Scholar 

  • Fink M (2001a) Catatonia: syndrome or schizophrenia subtype? Recognition and treatment. J Neural Transm 108: 637–644

    PubMed  CAS  Google Scholar 

  • Fink M (2001b) Treating neuroleptic malignant syndrome as catatonia. J Clin Psychopharmacol 21: 121–122

    PubMed  CAS  Google Scholar 

  • Fink M, Sackeim HA (1996) Convulsive therapy in schizophrenia? Schizophr Bull 22: 27–39

    PubMed  CAS  Google Scholar 

  • Fink M, Taylor A (2003) Catatonia. Cambridge University Press, New York

    Google Scholar 

  • Fink M, Taylor MA (2001) The many varieties of catatonia. Eur Arch Psychiatry Clin Neurosci 251[Suppl 1]: I8–13

    PubMed  Google Scholar 

  • Francis A (2000) Katatones Syndrom. In: Helmchen H, Henn F, Lauter H et al. (Hrsg) Schizophrene und affektive Störungen. Springer, Berlin Heidelberg New York Tokyo, S 583–596

    Google Scholar 

  • Frey R, Schreinzer D, Heiden A et al. (2001) Use of electroconvulsive therapy in psychiatry. Nervenarzt 72: 661–676

    PubMed  CAS  Google Scholar 

  • Fricchione G (1989) Catatonia: a new indication for benzodiazepines? Biol Psychiatry 26: 761–765

    PubMed  CAS  Google Scholar 

  • Fricchione G, Mann SC, Caroff SN (2000) Catatonia, lethal catatonia, and neuroleptic malignant syndrome. Psychiatr Ann 30(5): 347–355

    Google Scholar 

  • Fricchione GL, Cassem NH, Hooberman D et al. (1983) Intravenous lorazepam in neurolepticinduced catatonia. J Clin Psychopharmacol 3: 338–342

    PubMed  CAS  Google Scholar 

  • Frölich L, Fritze J (1993) Stupor, Katatonie und malignes neuroleptisches Syndrom. In: Riederer P, Laux G, Pöldinger W (Hrsg) Neuropsychopharmaka. Springer, Wien New York

    Google Scholar 

  • Gjessing L R (1974) A review of periodic catatonia. Biol Psychiatry 8: 23–45

    PubMed  CAS  Google Scholar 

  • Grabe HJ (2004) Ätiologie und Pathogenese. In: ASSION HJ, VOLZ HP (Hrsg) Malignes neuroleptisches Syndrom. G Thieme, Stuttgart

    Google Scholar 

  • Heinemann F, Assion HJ, Laux G (1997) Neuroleptic malignant syndrome from treatment with antidepressives. Fortschr Neurol Psychiatr 65: 208–213

    PubMed  CAS  Google Scholar 

  • Hermesh H, Aizenberg D, Weizman A et al. (1992) Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients. Br J Psychiatry 161: 254–257

    PubMed  CAS  Google Scholar 

  • Hesslinger B, Walden J, Normann C (2001) Acute and long-term treatment of catatonia with risperidone. Pharmacopsychiatry 34: 25–26

    PubMed  CAS  Google Scholar 

  • Huang T L (2001) Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge. Chang Gung Med J 24: 522–525

    PubMed  CAS  Google Scholar 

  • Kahlbaum K (1874) Die Katatonie. Hirschwald, Berlin

    Google Scholar 

  • Krüger S, Cooke RG, Spegg CC et al. (2003) Relevance of the catatonic syndrome to the mixed manic episode. J Affect Disord 74: 279–285

    PubMed  Google Scholar 

  • Laux G, Deister A (2003) Katatoner Stupor, malignes neuroleptisches Syndrom, Frühdyskinesie, akute Dystonie. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie und Psychotherapie. Springer, Berlin Heidelberg New York Tokyo, S 1779–1781

    Google Scholar 

  • Lee JW, Robertson S (1997) Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case report. Ann Clin Psychiatry 9: 165–169

    PubMed  CAS  Google Scholar 

  • Levenson JL (1985) Neuroleptic malignant syndrome. Am J Psychiatry 142: 1137–1145

    PubMed  CAS  Google Scholar 

  • Lew TY, Tollefson G (1983) Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam. Biol Psychiatry 18: 1441–1446

    PubMed  CAS  Google Scholar 

  • Mann SC, Caroff SN, Fricchione G et al. (2000) Central dopamine hypoactivity and the pathogenesis of neuroleptic malignant syndrome. Psychiatr Ann 30(5): 363–374

    Google Scholar 

  • Maurer I (2004) MNS und neue Antipsychotika. In: Assion HJ, Volz HP (Hrsg) Malignes neuroleptisches Syndrom. G Thieme, Stuttgart New York

    Google Scholar 

  • Mcevoy JP, Lohr JB (1984) Diazepam for catatonia. Am J Psychiatry 141: 284–285

    PubMed  CAS  Google Scholar 

  • Möller HJ (2000) Medikamentöse Therapie der katatonen Schizophrenie. In: Möller HJ (Hrsg) Therapie psychiatrischer Erkrankungen. G Thieme, Stuttgart, S 235–237

    Google Scholar 

  • Naber D, Lambert M, Krausz M et al. (2000) Atypische Neuroleptika. UNI-MED Verlag, Bremen

    Google Scholar 

  • Nisijima K, Noguti M, Ishiguro T (1997) Intravenous injection of levodopa is more effective than dantrolene as therapy for neuroleptic malignant syndrome. Biol Psychiatry 41: 913–914

    PubMed  CAS  Google Scholar 

  • Northoff G (2002a) Katatonie zwischen Schizophrenie und Depression. Nervenheilkunde 21: 414–419

    Google Scholar 

  • Northoff G (2002b) Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology. J Neural Transm 109: 1453–1467

    PubMed  CAS  Google Scholar 

  • Northoff G, Demisch L, Wenke J et al. (1996) Plasma homovanillic acid concentrations in catatonia. Biol Psychiatry 39: 436–443

    PubMed  CAS  Google Scholar 

  • Northoff G, Eckert J, Fritze J (1997) Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine. J Neurol Neurosurg Psychiatry 62: 404–406

    PubMed  CAS  Google Scholar 

  • Northoff G, Steinke R, Nagel DC et al. (2000) Right lower prefronto-parietal cortical dysfunction in akinetic catatonia: a combined study of neuropsychology and regional cerebral blood flow. Psychol Med 30: 583–596

    PubMed  CAS  Google Scholar 

  • Northoff G, Wenke J, Demisch L et al. (1995) Catatonia: short-term response to lorazepam and dopaminergic metabolism. Psychopharmacology (Berl) 122: 182–186

    PubMed  CAS  Google Scholar 

  • Paul GE, Landers DF, Newman T (1990) Neuroleptic malignant syndrome. Nebr Med J 75: 46–49

    PubMed  CAS  Google Scholar 

  • Persing JS (1994) Neuroleptic malignant syndrome: an overview. 206 S D J Med 47: 51–55

    CAS  Google Scholar 

  • Philibert RA, Adam LA, Frank FM et al. (2001) Olanzapine usage associated with neuroleptic malignant syndrome. Psychosomatics 42: 528–529

    PubMed  CAS  Google Scholar 

  • Pope HG JR, Cole JO, Choras PT et al. (1986) Apparent neuroleptic malignant syndrome with clozapine and lithium. J Nerv Ment Dis 174: 493–495

    PubMed  Google Scholar 

  • Reddig S, Minnema AM, Tandon R (1993) Neuroleptic malignant syndrome and clozapine. Ann Clin Psychiatry 5: 25–27

    PubMed  CAS  Google Scholar 

  • Rosebush PI, Hildebrand AM, Furlong BG et al. (1990) Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry 51: 357–362

    PubMed  CAS  Google Scholar 

  • Rosebush PI, Mazurek MF (1996) Catatonia after benzodiazepine withdrawal. J Clin Psychopharmacol 16: 315–319

    PubMed  CAS  Google Scholar 

  • Sakkas P, Davis JM, Janicak PG et al. (1991) Drug treatment of the neuroleptic malignant syndrome. Psychopharmacol Bull 27: 381–384

    PubMed  CAS  Google Scholar 

  • Sass H, Hoff P (2003) Deskriptiv-psychopathologische Befunderhebung. In: Möller HJ, Laux G, Kapfhammer HP (Hrsg) Psychiatrie und Psychotherapie. Springer, Berlin Heidelberg New York Tokyo, S 382–399

    Google Scholar 

  • Sass H, Wittchen HU, Zaudig M (Hrsg) (1996) Diagnostisches und Statistisches Manual Psychischer Störungen DSM-IV. Hogrefe, Göttingen Bern Toronto Seattle, S 829–832

    Google Scholar 

  • Sauer H, Lauter H (1987) Electroconvulsive therapy. I. Effectiveness and side effects of electroconvulsive therapy. Nervenarzt 58: 201–209

    PubMed  CAS  Google Scholar 

  • Schreiber W (2004) Diagnostische Kriterien. In: Assion HJ, Volz H-P (Hrsg) Malignes neuroleptisches Syndrom. G Thieme, Stuttgart New York

    Google Scholar 

  • Sing KJ, Ramaekers GM, van Harten PN (2002) Neuroleptic malignant syndrome and quetiapine. Am J Psychiatry 159: 149–150

    PubMed  Google Scholar 

  • Spiess-Kiefer C (1989) Malignes neuroleptisches Syndrom. In: Hippius H, Rüther E, Schmauss M (Hrsg) Katatone und dyskinetische Syndrome. Springer, Berlin Heidelberg New York, S 171–195

    Google Scholar 

  • Susman VL (2001a) Clinical management of neuroleptic malignant syndrome. Psychiatr Q 72: 325–336

    PubMed  CAS  Google Scholar 

  • Susman VL (2001b) Clinical management of neuroleptic malignant syndrome. Psychiatr Q 72: 325–336

    PubMed  CAS  Google Scholar 

  • Trollor JN, Sachdev PS (1999) Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. Aust NZ J Psychiatry 33: 650–659

    CAS  Google Scholar 

  • Utili R, Boitnott JK, Zimmerman HJ (1977) Dantrolene-associated hepatic injury. Incidence and character. Gastroenterology 72: 610–616

    PubMed  CAS  Google Scholar 

  • Valevski A, Loebl T, Keren T et al. (2001) Response of catatonia to risperidone: two case reports. Clin Neuropharmacol 24: 228–231

    PubMed  CAS  Google Scholar 

  • Vogel H P (2002) In: Berzewski H, Nickel B (Hrsg) Neurologische und psychiatrische Notfälle. Urban & Fischer, München Jena

    Google Scholar 

  • Yamawaki S, Morio M, Katsamatsurim G (1993) Clinical evaluation and effective usage of dantrolene sodium in neuroleptic malignant syndrome. Kiso to Rinsyou, 27

    Google Scholar 

  • Zwil AS, Pelchat RJ (1994) ECT in the treatment of patients with neurological and somatic disease. Int J Psychiatry Med 24: 1–29

    PubMed  CAS  Google Scholar 

Literatur

  • Burn DJ (2002) Depression in Parkinson’s disease. Eur J Neurol 9[Suppl 3]: 44–54

    PubMed  Google Scholar 

  • Giovannoni G, O’Sullivan JD, Turner K et al. (2000) Hedonistic homeostatic dysregulation in patients with Parkinson’s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68: 423–428

    PubMed  CAS  Google Scholar 

  • Kraft E, Winkelmann J, Trenkwalder C et al. (1999) Visual hallucinations, white matter lesions and disease severity in Parkinson’s disease. Acta Neurol Scand 99: 362–367

    PubMed  CAS  Google Scholar 

  • Kuno S, Mizuta E, Yamasaki S (1997) Neuroleptic malignant syndrome in parkinsonian patients: risk factors. Eur Neurol 38[Suppl 2]: 56–59

    PubMed  Google Scholar 

  • Müller T (2002) Drug treatment of non-motor symptoms in Parkinson’s disease. Expert Opin Pharmacother 3: 381–388

    PubMed  Google Scholar 

  • PONDAL M, DEL SER T, BERMEJO F (1996) Anticholinergic therapy and dementia in patients with Parkinson’s disease. J Neurol 243: 543–546

    PubMed  CAS  Google Scholar 

  • Reimer J, Kuhlmann A, Müller T (2002) Neuroleptic malignant-like syndrome after rapid switch from bromocriptine to pergolide. Parkinsonism Relat Disord 9: 115–116

    PubMed  Google Scholar 

  • Sechi G, Manca S, Deiana GA et al. (1996) Acute hyponatremia and neuroleptic malignant syndrome in Parkinson’s disease. Prog Neuropsychopharmacol Biol Psychiatry 20: 533–542

    PubMed  CAS  Google Scholar 

  • WELLER M, KORNHUBER J (1992) A rationale for NMDA receptor antagonist therapy of the neuroleptic malignant syndrome. Med Hypotheses 38: 329–333

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Psychiatrische Universitätsklinik, Wilhelm-Klein-Straße 27, 4025, Basel, Schweiz

    K. Pinhard (Dr. med. prakt.) & F. Müller-Spahn (Prof. Dr. med.)

  2. Bezirksklinikum Gabersee, Gabersee 7, 83512, Wasserburg, Deutschland

    G. Laux (Prof. Dr. med., Dipl.-Psych.)

  3. Toxikologische Abteilung, II. Medizinische Klinik und Poliklinik, Klinikum rechts der Isar, TU München, Ismaninger Straße 22, 81675, München, Deutschland

    Th. Zilker (Prof. Dr. med.)

  4. Facharzt für Psychiatrie und Neurologie, Duisburger Straße 20, 10707, Berlin, Deutschland

    H. Berzewski (Prof. Dr. med.)

  5. Facharzt für Psychiatrie und Neurologie, Duisburger Straße 20, 10707, Berlin, Deutschland

    H. Berzewski (Prof. Dr. med.)

  6. Klinik für Psychiatrie und Psychotherapie, Bezirkskrankenhaus Augsburg, Dr. Mack-Straße 1, 86156, Augsburg, Deutschland

    Th. Messer (Dr. med.) & M. Schmauß (Prof. Dr. med.)

  7. St. Josef-Hospital, Neurologische Klinik, Ruhr-Universität, Gudrunstraße 56, 44791, Bochum, Deutschland

    Th. Müller (Prof. Dr. med.) & H. Przuntek (Prof. Dr. med.)

Authors
  1. K. Pinhard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Müller-Spahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Laux
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Th. Zilker
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Berzewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Berzewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Th. Messer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Schmauß
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Th. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. H. Przuntek
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinische Neurochemie, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universität Würzburg, Deutschland

    Peter Riederer

  2. Bezirksklinikum Gabersee Fachkrankenhaus für Psychiatrie, Psychotherapie, Psychosomatische Medizin und Neurologie, Akademisches Lehrkrankenhaus der Ludwig-Maximilians-Universität München, Wasserburg/Inn, Deutschland

    Gerd Laux

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag/Wien

About this chapter

Cite this chapter

Pinhard, K. et al. (2006). Pharmakotherapie neuropsychiatrischer Notfall- und Akutsituationen. In: Riederer, P., Laux, G. (eds) Neuro-Psychopharmaka Ein Therapie-Handbuch. Springer, Vienna. https://doi.org/10.1007/3-211-37774-3_1

Download citation

  • DOI: https://doi.org/10.1007/3-211-37774-3_1

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-22956-9

  • Online ISBN: 978-3-211-37774-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation